Rybelsus, the first oral GLP-1 receptor agonist, has shown a remarkable ability to enhance the management of type 2 diabetes. This groundbreaking medication works by mimicking the incretin hormones that the body usually produces to stimulate insulin secretion in response to meals. Rybelsus helps regulate blood sugar levels effectively. Patients…